Chemren Bio-Engineering Co., Ltd.

Description of:AT7519
AT7519 is a novel small molecule multi-cyclin-dependent kinase inhibitor. It selectively binds to and inhibits cyclin dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation.

Theoretical analysis:AT7519
M.Wt: 382.24
Formula: C16H17Cl2N5O2
Solubility: Unknown
Purity: >99%
Storage: at -20℃ 2 years
CAS No: 844442-38-2

Availability and price:AT7519
Pakage：25mg/50mg/100mg/250mg/500mg/1g/5g
Stock : in stock
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to : sales@chemrenpharm.com

Quality control data:
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days